Swiss Venture Capital Report 2021 Presentation (Swiss Venture Capital Report (startupticker))

Summary

• Swiss venture capital investment experienced a 7% decrease overall.p.3
• A total of CHF 4.9 billion was attributable to 35 start-ups, accounting for over 50% of funding into 3% of companies.p.9
• Life sciences returned to the top with over CHF 1.1 billion invested in the sector.p.10
• Cleantech recorded the highest growth in activity at +69%, while ICT grew by +29%.p.11
• Early stage Series A rounds reached a new record, expanding by +31%.p.13
• Rounds above CHF 10 million increased by 38%, lifting the overall median financing round to CHF 3 million.p.14

Key insights

1. Top 20 investment rounds accounted for 54% of total investments, marking the lowest share ever recorded.p.5
2. A total of 25 fund managers were actively fundraising during the period.p.7
3. There were 18 companies that raised more than CHF 100 million since 2012.p.8
4. Medtech experienced value growth of +109% while ICT and fintech experienced a -40% drop in mega-rounds.p.10
5. Later stage Medtech funding surged by +329%.p.13
6. The median financing round for fintech reached 4.5 million, representing a +210% increase.p.14
7. Basel-Stadt registered CHF 540 million invested, representing a 403% growth rate and 25% of total investment.p.18